Terms: = Kidney tumors AND TFE3, RCCP2, 7030, ENSG00000068323, TFEA
452 results:
1. A case of pancreatic PEComa with prominent inflammatory cell infiltration: the inflammatory subtype is a distinct histologic group of PEComa.
Tsukita H; Koyama K; Ishinari T; Takahashi A; Miyabe K; Umakoshi M; Yoshida M; Kudo-Asabe Y; Nishida A; Otsuka N; Yasui O; Kato I; Fukushima N; Goto A
Diagn Pathol; 2024 Apr; 19(1):59. PubMed ID: 38622713
[TBL] [Abstract] [Full Text] [Related]
2. Multiple and hereditary renal tumors: a review for radiologists.
Corral de la Calle MÁ; Encinas de la Iglesia J; Fernández Pérez GC; Fraino A; Repollés Cobaleda M
Radiologia (Engl Ed); 2024; 66(2):132-154. PubMed ID: 38614530
[TBL] [Abstract] [Full Text] [Related]
3. Cystic Features in Renal Epithelial Neoplasms and Their Increasing Clinical and Pathologic Significance.
Tretiakova M; Kwon JW; Paner GP
Adv Anat Pathol; 2024 May; 31(3):157-168. PubMed ID: 38525552
[TBL] [Abstract] [Full Text] [Related]
4. A nomogram based on tfe3 IHC results and clinical factors as a preliminary screening scheme for tfe3-rearranged renal cell carcinoma.
Li P; Xu Q; Chen M; Zhu J; Wang Y; Mumin MA; Huang K; Jiang Z; Liang H; Deng Q; Wang Z; Liao B; Chen W; Cao Y; Cao J; Luo J
Cancer Med; 2024 Mar; 13(5):e6813. PubMed ID: 38477529
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS).
Taylor AS; Mannan R; Pantanowitz L; Chinnaiyan AM; Dhanasekaran SM; Hrycaj S; Cao X; Chan MP; Lucas D; Wang XM; Mehra R
Med Oncol; 2024 Feb; 41(3):76. PubMed ID: 38393424
[TBL] [Abstract] [Full Text] [Related]
6. Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis.
Prakasam G; Mishra A; Christie A; Miyata J; Carrillo D; Tcheuyap VT; Ye H; Do QN; Wang Y; Reig Torras O; Butti R; Zhong H; Gagan J; Jones KB; Carroll TJ; Modrusan Z; Durinck S; Requena-Komuro MC; Williams NS; Pedrosa I; Wang T; Rakheja D; Kapur P; Brugarolas J
J Clin Invest; 2024 Feb; 134(7):. PubMed ID: 38386415
[TBL] [Abstract] [Full Text] [Related]
7. Sarcomatoid variant of Xp11 translocation renal cell carcinoma: A rare case report in an adult female.
Jagdale RV; Jain S; Pol JN; Khochikar MV
Indian J Pathol Microbiol; 2024; 67(1):178-181. PubMed ID: 38358216
[TBL] [Abstract] [Full Text] [Related]
8. Actual encounters of the kidney kind: Exploring 48 cases of renal collision tumors through the lens of literature.
Lerma LA; Pease G; Malleis J; Antic T; Hes O; Tretiakova M
Hum Pathol; 2024 Mar; 145():26-33. PubMed ID: 38340966
[TBL] [Abstract] [Full Text] [Related]
9. ASPSCR1-tfe3 reprograms transcription by organizing enhancer loops around hexameric VCP/p97.
Pozner A; Li L; Verma SP; Wang S; Barrott JJ; Nelson ML; Yu JSE; Negri GL; Colborne S; Hughes CS; Zhu JF; Lambert SL; Carroll LS; Smith-Fry K; Stewart MG; Kannan S; Jensen B; John CM; Sikdar S; Liu H; Dang NH; Bourdage J; Li J; Vahrenkamp JM; Mortenson KL; Groundland JS; Wustrack R; Senger DL; Zemp FJ; Mahoney DJ; Gertz J; Zhang X; Lazar AJ; Hirst M; Morin GB; Nielsen TO; Shen PS; Jones KB
Nat Commun; 2024 Feb; 15(1):1165. PubMed ID: 38326311
[TBL] [Abstract] [Full Text] [Related]
10. The GATOR2 complex maintains lysosomal-autophagic function by inhibiting the protein degradation of MiT/TFEs.
Yang S; Ting CY; Lilly MA
Mol Cell; 2024 Feb; 84(4):727-743.e8. PubMed ID: 38325378
[TBL] [Abstract] [Full Text] [Related]
11. tfe3-Splicing Factor Fusions Represent Functional Drivers and Druggable Targets in Translocation Renal Cell Carcinoma.
Damayanti NP; Cordova RA; Rupert C; Delle Fontane I; Shen L; Orsi S; Klunk AJ; Linehan WM; Staschke KA; Hollenhorst PC; Heppner DE; Pili R
Cancer Res; 2024 Apr; 84(8):1286-1302. PubMed ID: 38266162
[TBL] [Abstract] [Full Text] [Related]
12. Therapeutic strategies and predictive models for Xp11.2 translocation/tfe3 gene fusion renal cell carcinoma in adults based on data of two Chinese medical centers.
Yang Y; Zhao C; Wang Z; Liu F; Zhao M; Yang H; Chen J; Chen X; Shi M; Jiang D; Luo X; Duan Y; Bai Y
Aging (Albany NY); 2024 Jan; 16(2):1696-1711. PubMed ID: 38261736
[TBL] [Abstract] [Full Text] [Related]
13. Molecular Characterization of tfe3-Rearranged Renal Cell Carcinoma: A Comparative Study With Papillary and Clear Cell Renal Cell Carcinomas.
Wei S; Krause HB; Geynisman DM; Elliott A; Kutikov A; Uzzo RG; Pei J; Barata P; Carneiro B; Heath E; Ryan C; Farrell A; Nabhan C; Ali-Fehmi R; Naqash AR; Argani P; McKay RR
Mod Pathol; 2024 Feb; 37(2):100404. PubMed ID: 38104891
[TBL] [Abstract] [Full Text] [Related]
14. Genomic alterations and diagnosis of renal cancer.
Zhang X; Bolck HA; Rupp NJ; Moch H
Virchows Arch; 2024 Feb; 484(2):323-337. PubMed ID: 37999735
[TBL] [Abstract] [Full Text] [Related]
15. Multicystic Clear Cell Renal tumors With Low-grade Nuclear Features: Time to Include tfe3 Translocation-associated Carcinomas.
Cai Q; Gagan J; Koduru P; Cadeddu J; Shah RB; Kapur P; Palsgrove DN
Adv Anat Pathol; 2024 Jan; 31(1):34-42. PubMed ID: 37937590
[TBL] [Abstract] [Full Text] [Related]
16. PEComa with ASPSCR1::tfe3 fusion: expanding the molecular genetic spectrum of tfe3-rearranged PEComa with an emphasis on overlap with alveolar soft part sarcoma.
Zhao M; Huang Y; Yin X; Xu J; Sun Y; Wang J
Histopathology; 2024 Feb; 84(3):482-491. PubMed ID: 37936565
[TBL] [Abstract] [Full Text] [Related]
17. LncRNA like NMRK2 mRNA functions as a key molecular scaffold to enhance mitochondrial respiration of NONO-tfe3 rearranged renal cell carcinoma in an NAD
Chen Y; Lu Y; Yang L; Ma W; Dong Y; Zhou S; Liu N; Gan W; Li D
J Exp Clin Cancer Res; 2023 Sep; 42(1):252. PubMed ID: 37770905
[TBL] [Abstract] [Full Text] [Related]
18. NONO::tfe3 fusion cutaneous epithelioid and spindle cell tumor: A case series.
See SHC; Olivares S; Kulkarni M; Dhillon SK; Fumero-Velazquez MS; Hagstrom MNE; Gerami P
J Cutan Pathol; 2023 Nov; 50(11):956-962. PubMed ID: 37606377
[TBL] [Abstract] [Full Text] [Related]
19. AKR1B10 Is a New Sensitive and Specific Marker for Fumarate Hydratase-Deficient Renal Cell Carcinoma.
Zheng L; Zhang X; Pan X; Huang Z; Zhang M; Xian J; Wei Y; Nie L; Zhang M; Gong J; Chen X; Zhou Q; Zeng H; Chen N
Mod Pathol; 2023 Nov; 36(11):100303. PubMed ID: 37580017
[TBL] [Abstract] [Full Text] [Related]
20. Establishment and Characterization of a
Ishiguro M; Fukushige T; Iwasaki H
Anticancer Res; 2023 Aug; 43(8):3463-3470. PubMed ID: 37500159
[TBL] [Abstract] [Full Text] [Related]
[Next]
